PCSK9 inhibitor
6 papers
- Human trial1
- Humans3
- In silico1
Latest
5 in 12 monthsArchives of Medical Research
Mexican Registry of Dyslipidemias of the Mexican Institute of Social Security: Lipid Profiles in Patients at High and Very High Cardiovascular Risk
Cross-sectional study in peopleDyslipidemia
AHA Scientific Sessions 2025 Abstract
FRAGILITY INDICES OF LIPID-LOWERING RANDOMIZED CONTROLLED TRIALS
Computational studyInterventions
AHA Scientific Sessions 2025 Abstract
Aggressive Lipid Lowering Differentially Impacts the Vascular Endothelium in Diabetic vs Healthy Individuals. Findings from the American Heart Association Cardiometabolic Health Strategically Focused Research Network
Non-randomised trial in peopleInterventions
AHA Scientific Sessions 2025 Abstract
Impact of Escalating Lipid-Lowering Therapy on Coronary Artery Calcium Progression and Lipid Biomarkers
Cohort study of 123 peopleInterventions
AHA Scientific Sessions 2025 Abstract
Assessment of Lipid-Lowering Therapy and Atherosclerotic Cardiovascular Disease Outcomes in Patients with Familial Hypercholesterolemia: Insights from the NIH All Of Us Dataset
Cohort study of 15,804 peopleFamilial hypercholesterolemia